Table 2.

IIEF domain score other than EF domain in the two groups

	Avanafil (n = 108)	Sildenafil (n = 103)	P‐value
End of week 4
Orgasmic function	3.1 ± 2.0 (2.7–3.5)	2.3 ± 2.0 (1.9–2.7)	<0.01
Sexual desire	2.0 ± 1.8 (1.6–2.3)	1.5 ± 1.9 (1.2–1.9)	0.08
Intercourse satisfaction	4.0 ± 2.8 (3.5–4.6)	3.6 ± 2.9 (3.1–4.2)	0.28
Overall satisfaction	2.7 ± 2.0 (2.3–3.1)	2.3 ± 2.0 (1.9–2.7)	0.11
End of week 8
Orgasmic function	4.1 ± 1.8 (3.8–4.5)	3.5 ± 1.9 (3.2–3.9)	0.02
Sexual desire	3.1 ± 1.8 (2.8–3.5)	2.6 ± 1.9 (2.2–3.0)	0.03
Intercourse satisfaction	5.4 ± 2.7 (4.9–6.0)	4.8 ± 2.9 (4.3–5.4)	0.11
Overall satisfaction	4.2 ± 1.9 (3.8–4.5)	3.5 ± 2.1 (3.1–3.9)	0.02
End of week 12
Orgasmic function	4.7 ± 1.8 (4.3–5.0)	4.1 ± 2.1 (3.7–4.5)	0.02
Sexual desire	3.6 ± 1.9 (3.3–4.0)	3.1 ± 2.1 (2.7–3.5)	0.04
Intercourse satisfaction	6.2 ± 2.6 (5.7–6.6)	5.5 ± 3.1 (4.9–6.1)	0.07
Overall satisfaction	4.8 ± 1.8 (4.5–5.2)	4.1 ± 2.3 (3.7–4.6)	0.01

Data expressed as mean ± SD (95% CI). All scores are change as compared with baseline. P‐value based on unpaired t‐test.